Kaiser Permanente: Updates on COVID-19 Coverage & CAA RxDC Reporting

What to know about COVID-19 coverage after May 11, 2023

As a reminder, the federal COVID-19 public health emergency is ending on May 11, 2023.

In California, COVID-19 vaccines, testing, and treatment (therapeutics) will continue to be provided and covered at $0 cost-share, in compliance with California law for fully insured health plans.

Kaiser Permanente will share more details on how coverage may change as they become available.

For additional details about the end of the federal COVID-19 public health emergency, visit account.kp.org.

CAA RxDC reporting terminated group outreach

In March, Kaiser Permanente contacted current customers and brokers to request group specific information required for Kaiser Permanente to complete aggregated reports for pharmacy reporting under the Consolidated Appropriations Act (CAA), 2021. To help ensure compliance with the reporting requirements, groups were required to provide specific information via Kaiser Permanente's form by April 3, 2023.

Kaiser Permanente set the April 3 deadline to allow them to identify and remediate any issues with this complex process before the Centers for Medicare & Medicaid Services’ (CMS) June 1, 2023 due date. In working with the data submitted by April 3, they found that their original outreach inadvertently omitted groups that terminated their coverage with Kaiser Permanente prior to the original outreach. Kaiser Permanente will be sending emails directly to the identified groups requesting they submit the needed information for their company by 5 p.m. PT on May 18, 2023.

To remain on track to meet the CMS submission deadline, Kaiser Permanente is only accepting data from the cohort previously omitted.

If a group has questions, they can contact SAM-RxDC@kp.org.